Swiss eye care firm Alcon’s quarterly revenue rises, driven by product launches

By Simon Ferdinand Eibach

Gdansk, May 6 (Reuters) – Swiss-American eye care company Alcon reported ​a 10% rise ‌in its quarterly revenue, citing recent product launches as main drivers.

• Alcon’s net sales rose ‌to $2.69 ​billion in the ⁠first quarter of ⁠2026, from $2.451 reported a year earlier

• Sales missed $2.71 billion estimates by analysts polled ​by LSEG

• Alcon’s operating earnings amounted to $292 million ⁠in the first ⁠quarter, falling 32% ​from a year earlier

• The ​company hiked its full-year guidance ‌for diluted earnings per shares growth to 10%-13% from 9%-12% as it announced ⁠a $1.5 billion share repurchase program with a plan to cancel the ⁠acquired ‌shares

• Alcon launched ⁠10 new products in ​the ‌first quarter of 2026, ​including ⁠Clareon TruPlus IOL, the next generation of monofocal and toric lenses for cataract surgery

(Reporting by Simon Ferdinand Eibach; Editing by ​Mrigank Dhaniwala)